🇺🇸 FDA
Drug

zongertinib

Brand: HERNEXEOS

approved

Quick answer

zongertinib (HERNEXEOS), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
zongertinib
Brand
HERNEXEOS
Route
ORAL
Formulation
TABLET

Related news

Boehringer Ingelheim's Zongertinib Shows Promise for HER2-Mutant Lung Cancer in NEJM Study
NewsNon-small cell lung cancer (NSCLC)Apr 17, 2026

Boehringer Ingelheim's Zongertinib Shows Promise for HER2-Mutant Lung Cancer in NEJM Study

Boehringer Ingelheim's zongertinib demonstrates efficacy in HER2-mutant NSCLC patients, with Phase 1b Beamion LUNG-1 results published in NEJM following FDA approval.

James Chen, PharmD

Frequently asked questions

What is zongertinib?

zongertinib (HERNEXEOS), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for zongertinib?

HERNEXEOS is a marketed brand name for zongertinib. Check FDA Drugs@FDA for the current US label holder.